The Endocannabinoid System as a Target for the Treatment of Visceral Obesity and Metabolic Syndrome

@article{Kyrou2006TheES,
  title={The Endocannabinoid System as a Target for the Treatment of Visceral Obesity and Metabolic Syndrome},
  author={I. Kyrou and G. Valsamakis and C. Tsigos},
  journal={Annals of the New York Academy of Sciences},
  year={2006},
  volume={1083}
}
Abstract:  The endogenous cannabinoid system is a novel, remarkably elaborate physiological signaling system, comprising the recently identified endogenous cannabinoid ligands, their corresponding selective receptors, and the machinery of proteins and enzymes that is involved in their biosynthesis, release, transport, and degradation. This system extends widely in both the central nervous system (CNS) and the periphery and exhibits a variety of actions implicated in vital functions (e.g… Expand
View on Wiley
ncbi.nlm.nih.gov
33 Citations
Highly Influential Citations
1
Background Citations
7

33 Citations

Citation Type

Citation Type

CB1 receptor antagonism: biological basis for metabolic effects
  • 70
The Endocannabinoid System as a Novel Approach for Managing Obesity
  • J. Lillo
  • Medicine
  • The Journal of the American Osteopathic Association
  • 2007
  • 8
  • PDF
Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists.
  • 45
The challenge of treating obesity: the endocannabinoid system as a potential target.
  • 22
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.
  • 91
  • Highly Influenced
  • PDF
Anti-neuroinflammatory activity of a novel cannabinoid derivative by inhibiting the NF-κB signaling pathway in lipopolysaccharide-induced BV-2 microglial cells.
  • 23
Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: efficacy.
  • 13
Cannabinoids in Eating Disorders and Obesity
  • 9
18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity.
  • 16
Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice
  • 96
...
1
2
3
4
...

References

SHOWING 1-10 OF 135 REFERENCES
Food for thought: endocannabinoid modulation of lipogenesis.
  • 50
  • PDF
The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
  • 755
  • PDF
Endocannabinoids in the central nervous system--an overview.
  • E. Fride
  • Medicine, Biology
  • Prostaglandins, leukotrienes, and essential fatty acids
  • 2002
  • 185
The endocannabinoid system: a general view and latest additions
  • 451
Endocannabinoids in the regulation of appetite and body weight
  • T. Kirkham
  • Psychology, Medicine
  • Behavioural pharmacology
  • 2005
  • 173
  • PDF
Endogenous cannabinoid system as a modulator of food intake
  • 303
  • PDF
The endocannabinoid system as a target for therapeutic drugs.
  • 436
Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice.
  • 62
  • PDF
Activation of the peripheral endocannabinoid system in human obesity.
  • 625
  • PDF
Central and Peripheral Signaling Mechanisms Involved in Endocannabinoid Regulation of Feeding: A Perspective on the Munchies
  • 35
...
1
2
3
4
5
...